Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ)

Shenzhen - Shenzhen Delayed Price. Currency in CNY
42.11-0.35 (-0.82%)
At close: 03:04PM CST
Advertisement

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

No. 238 Tianshan Street
High-tech Industrial Development Zone
Shijiazhuang 050035
China
86 311 8590 1311
https://www.yiling.cn

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees15,155

Key Executives

NameTitlePayExercisedYear Born
Mr. Xiang Jun WuGM & DirectorN/AN/A1975
Mr. Chen Guang LiCFO & DirectorN/AN/A1973
Ms. Wei WangDeputy GM & Director of Admin. DepartmentN/AN/A1970
Mr. Wei Dong XuDirector of HR & DirectorN/AN/A1968
Ms. Rui WuSec. of the Board & Non-Independent DirectorN/AN/A1980
Mr. Shao Hua ZhaoDeputy Gen. Mang.N/AN/A1966
Ms. Yue Zhi HanProduction Management Committee Director & Deputy GMN/AN/A1966
Ms. Qiu Lian ZhangDeputy GM & Non-Independent DirectorN/AN/A1970
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of medicine primarily in China. The company operates through Chemical and Biological Medicine, and Health Industry segments. It offers drugs for cardiac and premature ventricular beats, sinus bradycardia, chronic heart failure, integrated rhythm regulation, cold and respiratory, cardiovascular and cerebrovascular diseases, diabetes field, tumor medication, and others. The company sells its products through physical display and online. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.

Corporate Governance

Shijiazhuang Yiling Pharmaceutical Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement